McKesson Stock Forecast, Price & News

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" McKesson stock.
View analyst ratings for McKesson or view top-rated stocks.

Wall Street analysts have given McKesson a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but McKesson wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

McKesson saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 2,050,000 shares, a decline of 35.5% from the August 15th total of 3,180,000 shares. Based on an average trading volume of 1,110,000 shares, the days-to-cover ratio is currently 1.8 days. Approximately 1.3% of the company's shares are short sold.
View McKesson's Short Interest.

McKesson is scheduled to release its next quarterly earnings announcement on Tuesday, November 2nd 2021.
View our earnings forecast for McKesson.

McKesson Co. (NYSE:MCK) announced its earnings results on Wednesday, August, 4th. The company reported $5.56 EPS for the quarter, topping the Zacks' consensus estimate of $4.09 by $1.47. The company had revenue of $62.67 billion for the quarter, compared to the consensus estimate of $60.16 billion. McKesson had a positive trailing twelve-month return on equity of 216.39% and a negative net margin of 1.83%. The business's revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the firm earned $2.77 EPS.
View McKesson's earnings history.

McKesson's stock was trading at $135.17 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, MCK stock has increased by 53.7% and is now trading at $207.77.
View which stocks have been most impacted by COVID-19.

McKesson announced a quarterly dividend on Monday, July 26th. Shareholders of record on Wednesday, September 1st will be given a dividend of $0.47 per share on Friday, October 1st. This represents a $1.88 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date of this dividend is Tuesday, August 31st. This is a boost from McKesson's previous quarterly dividend of $0.42.
View McKesson's dividend history.

McKesson pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.90%. The dividend payout ratio of McKesson is 10.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, McKesson will have a dividend payout ratio of 8.91% next year. This indicates that McKesson will be able to sustain or increase its dividend.
View McKesson's dividend history.

McKesson announced that its board has approved a stock buyback program on Tuesday, February 2nd 2021, which authorizes the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 6.9% of its stock through open market purchases. Stock buyback programs are generally an indication that the company's board believes its stock is undervalued.

McKesson updated its FY 2022 earnings guidance on Wednesday, September, 1st. The company provided earnings per share guidance of $19.800-$20.400 for the period, compared to the Thomson Reuters consensus EPS estimate of $19.230. The company issued revenue guidance of $247.76 billion-$254.90 billion, compared to the consensus revenue estimate of $249.75 billion.

8 analysts have issued twelve-month price objectives for McKesson's shares. Their forecasts range from $166.00 to $261.00. On average, they expect McKesson's stock price to reach $224.13 in the next twelve months. This suggests a possible upside of 7.9% from the stock's current price.
View analysts' price targets for McKesson or view top-rated stocks among Wall Street analysts.

220 employees have rated McKesson CEO Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among McKesson's employees.

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of MCK's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include The Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC), AT&T (T), JPMorgan Chase & Co. (JPM), UnitedHealth Group (UNH) and The Home Depot (HD).

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

McKesson's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.22%), BlackRock Inc. (8.55%), State Street Corp (4.44%), Massachusetts Financial Services Co. MA (3.54%), FMR LLC (2.68%) and Invesco Ltd. (2.33%). Company insiders that own McKesson stock include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Marie L/Ca Knowles, Sundeep G Reddy, Thomas L Rodgers and Tracy Faber.
View institutional ownership trends for McKesson.

MCK stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Bank of New York Mellon Corp, Glenmede Trust Co. NA, Caisse DE Depot ET Placement DU Quebec, Boston Partners, Massachusetts Financial Services Co. MA, Dimensional Fund Advisors LP, and Marshall Wace North America L.P.. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, Sundeep G Reddy, Thomas L Rodgers, and Tracy Faber.
View insider buying and selling activity for McKesson or view top insider-selling stocks.

MCK stock was purchased by a variety of institutional investors in the last quarter, including Amundi, Border to Coast Pensions Partnership Ltd, Laurion Capital Management LP, Macquarie Group Ltd., FMR LLC, Point72 Asset Management L.P., Worldquant Millennium Advisors LLC, and Renaissance Technologies LLC.
View insider buying and selling activity for McKesson or or view top insider-buying stocks.

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MCK stock can currently be purchased for approximately $207.77.

McKesson has a market capitalization of $32.14 billion and generates $238.23 billion in revenue each year. The company earns $-4,539,000,000.00 in net income (profit) each year or $17.21 on an earnings per share basis.

McKesson employs 76,000 workers across the globe.

The following companies are subsidiares of McKesson: A.L.I. Technologies, AMISYS Managed Care Systems, Abaton.com, Access Health, Biologics, Celesio, ClarusONE Sourcing Services LLP, CoverMyMeds, D & K Healthcare Resources, Drug Trading Co. Ltd., EN-Chart Scanning Program, Emendo, Enterprise Systems Inc., HBO & Company, HPR, HealthCom Partners, HealthQx, IMNET Systems, LloydsDirect, MED3000, McKesson Europe AG, McKesson International Bermuda IP5A Limited, McKesson Medical-Surgical Inc., McKesson Medical-Surgical Supply Chain Services LLC, McKesson Sourcing Services Inc., McKesson Specialty Care Distribution LLC, McKesson Strategic Services Limited, McKesson UK Finance I Limited, McKesson US Finance Corporation, McQueary Brothers, MedVentive, Medcon, MediVation Inc., Medical Specialties Distributors, Medis Health And Pharmaceutical Services, Moore Medical, NDCHealth, Northstar Healthcare Holdings Unlimited Company, Oncology Therapeutics Network, PSS World Medical, Per-Se Technologies, Portico Systems, Practice Partner, RedLine HealthCare, RelayHealth, Rexall, Rosebud Solutions, RxCrossroads, Sterling Medical Services LLC, UDG Healthcare, US Oncology, US Oncology Holdings Inc., Vantage Oncology, Vivalog Technologies, Well.ca, and peerVue.

McKesson was founded in 1833.

The official website for McKesson is www.mckesson.com.

McKesson is headquartered at 6555 STATE HWY 161, IRVING TX, 75039.

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at (972) 446-4800 or via email at [email protected]